Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Kaleido Biosciences Inc (KLDO)

Kaleido Biosciences Inc (KLDO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 178,574
  • Shares Outstanding, K 30,063
  • Annual Sales, $ 0 K
  • Annual Income, $ -61,744 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.13
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 01/29/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    Medical - Biomedical

    Indices Russell 2000

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.70
  • Number of Estimates 1
  • High Estimate -0.70
  • Low Estimate -0.70
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.97 +19.52%
on 12/11/19
9.40 -36.81%
on 11/25/19
-0.17 (-2.78%)
since 11/13/19
3-Month
4.80 +23.75%
on 10/17/19
9.97 -40.42%
on 09/20/19
-3.22 (-35.15%)
since 09/13/19

Most Recent Stories

More News
Flagship Pioneering Names Dr. Nancy Simonian, CEO of Syros, as Recipient of the 2019 Pioneering Leader Award

Flagship Pioneering has announced the recipient of the firm's annual Pioneering Leader Award. The 2019 award recognizes Nancy Simonian, M.D., CEO of Syros Pharmaceuticals (NASDAQ: SYRS), a company that...

AXLA : 3.48 (-1.97%)
DNLI : 18.90 (+0.91%)
EVLO : 4.38 (-1.13%)
KLDO : 5.94 (+0.17%)
MRNA : 18.62 (+0.92%)
RUBY : 13.11 (+1.24%)
MCRB : 4.20 (-3.67%)
SYRS : 4.59 (-0.65%)
Flagship Pioneering Appoints Prakash Raman, Ph.D. as Senior Partner and Chief Business Development Officer

Flagship Pioneering, a unique life sciences innovation enterprise, today announced the appointment of Prakash Raman, Ph.D. to the post of Senior Partner and the newly created role of Chief Business Development...

NVS : 92.99 (-0.08%)
AXLA : 3.48 (-1.97%)
DNLI : 18.90 (+0.91%)
EVLO : 4.38 (-1.13%)
KLDO : 5.94 (+0.17%)
MRNA : 18.62 (+0.92%)
RUBY : 13.11 (+1.24%)
MCRB : 4.20 (-3.67%)
SYRS : 4.59 (-0.65%)
Kaleido Biosciences Announces Appointment of Jean Mixer to its Board of Directors

Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health, today announced...

KLDO : 5.94 (+0.17%)
Kaleido Biosciences to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health, today announced...

MS : 50.24 (-0.89%)
KLDO : 5.94 (+0.17%)
Kaleido Biosciences Announces Appointment of Theo Melas-Kyriazi to its Board of Directors

Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health,...

KLDO : 5.94 (+0.17%)
EVLO : 4.38 (-1.13%)
Kaleido Biosciences Announces Closing of Initial Public Offering

Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve...

MS : 50.24 (-0.89%)
KLDO : 5.94 (+0.17%)
Nasdaq Welcomes Kaleido Biosciences, Inc. (Nasdaq: KLDO) to the Nasdaq Stock Market

Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach focused on leveraging the potential of the microbiome organ to treat disease...

KLDO : 5.94 (+0.17%)
NDAQ : 104.48 (+0.34%)
Kaleido Biosciences Announces Pricing of Initial Public Offering

Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve...

MS : 50.24 (-0.89%)
KLDO : 5.94 (+0.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade KLDO with:

Business Summary

Kaleido Biosciences Inc. is a clinical-stage healthcare company. It focuses on leveraging the potential of the microbiome organ to treat disease and improve human health. The Company's product candidates are Microbiome Metabolic Therapies(TM), which are designed to modulate the metabolic output and profile...

See More

Key Turning Points

2nd Resistance Point 7.01
1st Resistance Point 6.47
Last Price 5.94
1st Support Level 5.61
2nd Support Level 5.29

See More

52-Week High 19.00
Fibonacci 61.8% 13.58
Fibonacci 50% 11.90
Fibonacci 38.2% 10.22
Last Price 5.94
52-Week Low 4.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar